Galderma’s investigational prurigo nodularis drug hits Phase II endpoint
Prurigo nodularis is a rare, potentially debilitating, chronic skin condition with thick skin nodules covering large body areas and associated severe pruritus.
Read More
Tag: Phase II
Verona initiates Phase II trial for COPD powder inhaler
Verona has announced the start of a Phase II clinical trial to evaluate a dry powder inhaler formulation of RPL554 in patients with moderate to severe chronic obstructive pulmonary disease.
Read More
Eisai kicks off mid-stage study of sleep drug
Eisai has kicked off a mid-stage study assessing its potential first-in-class experimental therapy lemborexant in Alzheimer’s patients with Irregular Sleep-Wake Rhythm Disorder (ISWRD).
Read More
AZ pulls plug on Phase II asthma trial
AstraZeneca has called time on a mid-stage trial assessing an experimental inhaled interferon beta licensed from Southampton, UK-based group Synairgen.
Read More
- Storm Therapeutics and AlidaBio launch collaboration to advance RNA‑targeting cancer therapies
- Excellence adventure
- MHRA approves Nucala for eosinophilic COPD in adults on triple therapy
- Bial launches new sublingual Parkinson’s treatment in UK
- Acesion Pharma launches phase 2 trial of AP31969 in atrial fibrillation
